Nuclear IRF-1 expression as a mechanism to assess “Capability” to express PD-L1 and response to PD-1 therapy in metastatic melanoma

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

So far, Dimensions has found 33 publications that cite this research output.

Article in Cancers (March 2024)

Article in International Journal of Molecular Sciences (February 2024)

Article in Frontiers in Immunology (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.